Clinical Trials Directory

Trials / Completed

CompletedNCT06931210

Study of AI-based Prediction Models for Exercise-Induced Gut Microbiota Alterations in Patients With Type 2 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
79 (actual)
Sponsor
Shanghai 6th People's Hospital · Academic / Other
Sex
All
Age
35 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study is a randomized controlled clinical trial. The participants will be randomized into two groups in a 1:1 ratio: exercise intervention and sedentary control group. The participants (50 participants per group) will undergo a 16-week intervention. Participants in the control group will maintain their sedentary lifestyle unchanged, and the exercise intervention group will receive combined aerobic and resistance exercise training. This study aims to compare the changes in gut microbiota before and after exercise intervention in patients. It will validate and optimize a cross-species microbiota mapping model through an independent exercise intervention clinical trial. Additionally, it will comprehensively assess the effects of combined aerobic and resistance exercise on patients' body composition, the severity of fatty liver, and glucose-lipid metabolism indicators. The study will also analyze the correlation between dynamic changes in the gut microbiota and the improvement of clinical symptoms in patients with type 2 diabetes after exercise intervention, elucidating the regulatory mechanisms of microbiota remodeling in exercise-mediated metabolic benefits.

Conditions

Interventions

TypeNameDescription
OTHERSedentary behaviorPatients in the control group will maintain their sedentary lifestyle unchanged.
BEHAVIORALExercise interventionThe intervention will include a combination of aerobic and resistance exercises, performed three times per week. Each session will last 80 minutes. Aerobic and resistance training will include cycling, chest press, rowing, abdominal and back muscle exercises, as well as leg strength training.

Timeline

Start date
2025-04-18
Primary completion
2025-08-05
Completion
2025-08-27
First posted
2025-04-17
Last updated
2025-09-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06931210. Inclusion in this directory is not an endorsement.